MENU
INCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Incyte (INCY) Ownership - Who owns Incyte?

Incyte focuses on the discovery and development of small-molecule drugs... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.04B
P/E Ratio
17.30
Total Cash
2.93B
Projected Growth
0.13
Total Debt
41.27M
Revenue
4.81B
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash/Share
14.92
Total Debt/Equity
N/A
Revenue/Share
23.91 USD as % of share price

Fundamentals

INCY
Capitalization
20B
P/E Ratio
17.30
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash
2.93B
Total Cash/Share
14.92
Total Debt
41.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.13
Revenue/Share (as % of the share price)
23.91%
Revenue
4.81B
ROE
N/A
Book Value
4.65B
P/B Ratio
4.31
Cash Flow
N/A
Earnings
6.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
196K
Current Ratio
3.20
Current Revenue Per Employee
521964.10
Dividends Per Share - Security
N/A
EBITDA
1.68B
Float
N/A
Float - Current
N/A
Gross Income Margin
92.75
Revenue To Assets
20.96
Shares Held By Institutions
30.5B
Shares Outstanding - Current
196M
Total Liabilities
1.68B
Total Volume MTD
N/A
Value
-1
Gain YTD
47.763
View a ticker or compare two or three
INCY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INCY showed earnings on October 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com